Repository logo
 
Publication

Crossing barriers: the burden of inflammatory bowel disease across Western Europe

2023Journal article Open access
Simple item page
dc.contributor.authorKumar, Aditi
dc.contributor.authorYassin, Nuha
dc.contributor.authorMarley, Alexandra
dc.contributor.authorBellato, Vittoria
dc.contributor.authorFoppa, Caterina
dc.contributor.authorPellino, Gianluca
dc.contributor.authorMyrelid, Pär
dc.contributor.authorMillan, Monica
dc.contributor.authorGros, Beatriz
dc.contributor.authorAvellaneda, Nicolas
dc.contributor.authorCatalan-Serra, Ignacio
dc.contributor.authorEl-Hussuna, Alaa
dc.contributor.authorCunha Neves, João A.
dc.contributor.authorRoseira, Joana
dc.contributor.authorCunha, Miguel F.
dc.contributor.authorVerstockt, Bram
dc.contributor.authorBettenworth, Dominik
dc.contributor.authorMege, Diane
dc.contributor.authorBrookes, Matthew J.
dc.date.accessioned2024-01-18T11:14:05Z
dc.date.available2024-01-18T11:14:05Z
dc.date.issued2023
dc.description.abstractAn estimated 2.5-3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently resulting in a significant cost to the healthcare system of an estimated 4.6-5.6 billion euros per year. Hospitalisation and surgical resection rates are generally on a downward trend, which is contrary to the rising cost of novel medication. This signifies a large part of healthcare cost and burden. Despite publicly funded healthcare systems in most European countries, there is still wide variation in how patients receive and/or pay for biologic medication. This review will provide an overview and discuss the different healthcare systems within Western Europe and the barriers that affect overall management of a changing IBD landscape, including differences to hospitalisation and surgical rates, access to medication and clinical trial participation and recruitment. This review will also discuss the importance of standardising IBD management to attain high-quality care for all patients with IBD.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1177/17562848231218615pt_PT
dc.identifier.issn1756-283X
dc.identifier.urihttp://hdl.handle.net/10400.1/20313
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSage Publicationspt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectCrohn’s diseasept_PT
dc.subjectDisease burdenpt_PT
dc.subjectHealthcarept_PT
dc.subjectInflammatory bowel diseasept_PT
dc.subjectTrialspt_PT
dc.subjectUlcerative colitispt_PT
dc.titleCrossing barriers: the burden of inflammatory bowel disease across Western Europept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleTherapeutic Advances in Gastroenterologypt_PT
oaire.citation.volume16pt_PT
person.familyNameRoseira
person.familyNameCunha
person.givenNameJoana
person.givenNameMiguel F.
person.identifier.orcid0000-0002-5098-8729
person.identifier.orcid0000-0002-7353-2425
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication077331f1-402e-455f-8e16-e475d62bc73a
relation.isAuthorOfPublication264b8ff0-a5d3-4296-acce-6b3d306485d8
relation.isAuthorOfPublication.latestForDiscovery077331f1-402e-455f-8e16-e475d62bc73a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
kumar-et-al-2023-crossing-barriers-the-burden-of-inflammatory-bowel-disease-across-western-europe.pdf
Size:
230.06 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ABC2-Artigos (em revistas ou actas indexadas)